A very recent article in the journal Nature, ‘Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia’ reminds us of the risk that PV and ET patients face regarding other cancers.
The 2026 US physician guidelines were released earlier this year and the 2026 US patient guidelines for MPNs have recently been released and are free to access.
A team at Peter MacCallum Cancer Centre in Melbourne will be running a monthly peer support group about work and cancer. The group is available both in-person and online.
Rare cancers struggle for visibility, and without targeted funding, progress is slow. Your support helps change that.
US cardiologist Dr Orly Leiva has a special research interest in MPNs and cardiovascular issues and has published several articles on this emerging area of MPN management. His latest article was published on 26 May 2026 and is free to access.
In April 2026, a review article was published from Italian haematologists titled, ‘Modern and multidisciplinary care in polycythemia vera’ (PV).
